98 related articles for article (PubMed ID: 9618321)
41. Validation of new methods.
Peters FT; Drummer OH; Musshoff F
Forensic Sci Int; 2007 Jan; 165(2-3):216-24. PubMed ID: 16781833
[TBL] [Abstract][Full Text] [Related]
42. Exploring current read-across applications and needs among selected U.S. Federal Agencies.
Patlewicz G; Lizarraga LE; Rua D; Allen DG; Daniel AB; Fitzpatrick SC; Garcia-Reyero N; Gordon J; Hakkinen P; Howard AS; Karmaus A; Matheson J; Mumtaz M; Richarz AN; Ruiz P; Scarano L; Yamada T; Kleinstreuer N
Regul Toxicol Pharmacol; 2019 Aug; 106():197-209. PubMed ID: 31078681
[TBL] [Abstract][Full Text] [Related]
43. Decisions to adopt new technologies at the hospital level: insights from Israeli medical centers.
Greenberg D; Peterburg Y; Vekstein D; Pliskin JS
Int J Technol Assess Health Care; 2005; 21(2):219-27. PubMed ID: 15921062
[TBL] [Abstract][Full Text] [Related]
44. Creation of a digital slide and tissue microarray resource from a multi-institutional predictive toxicology study in the rat: an initial report from the PredTox group.
Mulrane L; Rexhepaj E; Smart V; Callanan JJ; Orhan D; Eldem T; Mally A; Schroeder S; Meyer K; Wendt M; O'Shea D; Gallagher WM
Exp Toxicol Pathol; 2008 Aug; 60(4-5):235-45. PubMed ID: 18479893
[TBL] [Abstract][Full Text] [Related]
45. Development of a framework for international certification by OIE of diagnostic tests validated as fit for purpose.
Wright P; Edwards S; Diallo A; Jacobson R
Dev Biol (Basel); 2006; 126():43-51; discussion 324-5. PubMed ID: 17058480
[TBL] [Abstract][Full Text] [Related]
46. Current developments in food additive toxicology in the USA.
Hattan DG; Kahl LS
Toxicology; 2002 Dec; 181-182():417-20. PubMed ID: 12505345
[TBL] [Abstract][Full Text] [Related]
47. Meeting report: Validation of toxicogenomics-based test systems: ECVAM-ICCVAM/NICEATM considerations for regulatory use.
Corvi R; Ahr HJ; Albertini S; Blakey DH; Clerici L; Coecke S; Douglas GR; Gribaldo L; Groten JP; Haase B; Hamernik K; Hartung T; Inoue T; Indans I; Maurici D; Orphanides G; Rembges D; Sansone SA; Snape JR; Toda E; Tong W; van Delft JH; Weis B; Schechtman LM
Environ Health Perspect; 2006 Mar; 114(3):420-9. PubMed ID: 16507466
[TBL] [Abstract][Full Text] [Related]
48. Validation and acceptance of new and revised tests: a flexible but transparent process.
Zeiger E
Toxicol Lett; 2003 Apr; 140-141():31-5. PubMed ID: 12676448
[TBL] [Abstract][Full Text] [Related]
49. Status of acute systemic toxicity testing requirements and data uses by U.S. regulatory agencies.
Strickland J; Clippinger AJ; Brown J; Allen D; Jacobs A; Matheson J; Lowit A; Reinke EN; Johnson MS; Quinn MJ; Mattie D; Fitzpatrick SC; Ahir S; Kleinstreuer N; Casey W
Regul Toxicol Pharmacol; 2018 Apr; 94():183-196. PubMed ID: 29408321
[TBL] [Abstract][Full Text] [Related]
50. Skin sensitization testing needs and data uses by US regulatory and research agencies.
Strickland J; Daniel AB; Allen D; Aguila C; Ahir S; Bancos S; Craig E; Germolec D; Ghosh C; Hudson NL; Jacobs A; Lehmann DM; Matheson J; Reinke EN; Sadrieh N; Vukmanovic S; Kleinstreuer N
Arch Toxicol; 2019 Feb; 93(2):273-291. PubMed ID: 30377734
[TBL] [Abstract][Full Text] [Related]
51. Framework for validation and implementation of in vitro toxicity tests.
Goldberg AM; Frazier JM; Brusick D; Dickens MS; Flint O; Gettings SD; Hill RN; Lipnick RL; Renskers KJ; Bradlaw JA
In Vitro Cell Dev Biol Anim; 1993 Sep; 29A(9):688-92. PubMed ID: 8407711
[TBL] [Abstract][Full Text] [Related]
52. [Validation and regulatory acceptance criteria for alternative test methods].
Ohno Y
J Toxicol Sci; 1997 Aug; 22(3):APP 111-22. PubMed ID: 9379498
[No Abstract] [Full Text] [Related]
53. Predictive Models for Acute Oral Systemic Toxicity: A Workshop to Bridge the Gap from Research to Regulation.
Kleinstreuer NC; Karmaus A; Mansouri K; Allen DG; Fitzpatrick JM; Patlewicz G
Comput Toxicol; 2018 Nov; 8(11):21-24. PubMed ID: 30320239
[TBL] [Abstract][Full Text] [Related]
54. An evaluation of the performance of selected (Q)SARs/expert systems for predicting acute oral toxicity.
Nelms MD; Karmaus AL; Patlewicz G
Comput Toxicol; 2020 Nov; 16():. PubMed ID: 33163737
[TBL] [Abstract][Full Text] [Related]
55. The validation and acceptance of alternatives to animal testing.
Balls M; Fentem JH
Toxicol In Vitro; 1999; 13(4-5):837-46. PubMed ID: 20654558
[TBL] [Abstract][Full Text] [Related]
56. Why, when and how in vitro tests should be accepted into regulatory toxicology.
Fentem JH; Balls M
Toxicol In Vitro; 1994 Aug; 8(4):923-4. PubMed ID: 20693045
[TBL] [Abstract][Full Text] [Related]
57. Advances in the Development and Validation of Test Methods in the United States.
Casey WM
Toxicol Res; 2016 Jan; 32(1):9-14. PubMed ID: 26977254
[TBL] [Abstract][Full Text] [Related]
58. The role of validation in establishing the scientific credibility of predictive toxicology approaches intended for regulatory application.
Patterson EA; Whelan MP; Worth AP
Comput Toxicol; 2021 Feb; 17():100144. PubMed ID: 33681540
[TBL] [Abstract][Full Text] [Related]
59. Validation of alternative toxicity tests: Principles, practices and cases.
Clothier RH; Balls M
Toxicol In Vitro; 1990; 4(4-5):692-3. PubMed ID: 20702258
[TBL] [Abstract][Full Text] [Related]
60. A New Test for Diabetis.
Bidwell EC
Atlanta Med Surg J; 1861 Mar; 6(7):417-418. PubMed ID: 35826492
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
